Physician profile
Scott E Johnson
NPI 1407946262
$3,316.46
in general payments reported to CMS, 2019-2025
9 companies · $30.69 in 2025
The $30.69 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,389 · 2020: $29.99 · 2021: $50.45 · 2022: $188 · 2023: $387 · 2024: $242 · 2025: $30.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,232.42 | 2019-2024 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $393.25 | 2019-2025 | Renasys Go V2 Home, Pico 7, Collagenase Santyl |
| Bioventus LLC | $307.55 | 2022-2023 | Sonicone Clinic |
| Lifenet Health | $185.57 | 2023-2024 | Theragenesis Wound Matrix |
| Abbvie INC. | $115.33 | 2022-2024 | |
| Melinta Therapeutics, LLC | $28.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $21.06 | 2024 | Clenpiq |
| Medela LLC | $16.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.